Erin Borger

Chief Executive Officer at ExThera Medical Corp.

43 year

Health Technology

Consumer Services

Health Services

Profile

Erin R.
Borger is currently the Chief Executive Officer & Director at ExThera Medical Corp.
Mr. Borger previously worked as a Director at the National Parkinson Foundation, Inc. Mr. Borger also served as an Independent Director at Longeveron, Inc. Mr. Borger completed their undergraduate degree at Wofford College.

Erin Borger active positions

Companies	Position	Start
ExThera Medical Corp. ExThera Medical Corp. Medical/Nursing ServicesHealth Services ExThera Medical Corp. develops medical devices that address unmet clinical needs in the treatment of bloodstream infections and pathogen-reduction in blood banking. The company develops Seraph Microbind Affinity Blood Filter (Seraph), which captures and removes normal and drug-resistant bacteria, viruses, toxins, and pro-inflammatory cytokines from human blood; and offers solution for use in a dialysis, such as extracorporeal circuit for treating existing bloodstream infections. The company was founded in 2007 and is headquartered in Martinez, CA.	Chief Executive Officer	2023-11-14

All active positions of Erin Borger

Former positions of Erin Borger

Companies	Position	End
LONGEVERON INC.	Director/Board Member	2023-06-08
National Parkinson Foundation, Inc.	Director/Board Member	-

See the detail of Erin Borger's experience

Training of Erin Borger

Wofford College

Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Erin Borger's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
LONGEVERON INC.	Health Technology

Private companies	2
National Parkinson Foundation, Inc.	Health Technology
ExThera Medical Corp. ExThera Medical Corp. Medical/Nursing ServicesHealth Services ExThera Medical Corp. develops medical devices that address unmet clinical needs in the treatment of bloodstream infections and pathogen-reduction in blood banking. The company develops Seraph Microbind Affinity Blood Filter (Seraph), which captures and removes normal and drug-resistant bacteria, viruses, toxins, and pro-inflammatory cytokines from human blood; and offers solution for use in a dialysis, such as extracorporeal circuit for treating existing bloodstream infections. The company was founded in 2007 and is headquartered in Martinez, CA.	Health Services